NSB 2.56% 4.0¢ neuroscientific biopharmaceuticals ltd

Ann: Ethics Approval Granted for Early-Phase Clinical Trial, page-27

  1. 805 Posts.
    lightbulb Created with Sketch. 143
    "The main goal of early phase trials is to gain knowledge about the clinical suitability of novel compounds, without pursuing specific therapeutic purposes. Healthy volunteers usually represent the ideal model for conducting phase I clinical trials, in order to investigate pharmacokinetics and pharmacodynamics as well as to document safety and tolerability without interference by concomitant pathological conditions."
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $5.206M
Open High Low Value Volume
3.9¢ 4.0¢ 3.6¢ $5.263K 142.7K

Buyers (Bids)

No. Vol. Price($)
2 20181 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 125000 1
View Market Depth
Last trade - 15.40pm 28/06/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.